The recognition of the anaphylatoxins by their receptors (C3aR, C5aR1 and C5aR2) present at the surface of some tumor cells leads to the activation of the signaling pathways PI3K, Erk 1/2 and AKT. The gene discussed is C3AR1; the disease is neoplasm.